ERBB2 and breast carcinoma: Some of these factors are types of breast cancer, tumor mutation burden (TMB), tumor-infiltrating lymphocytes (TILs), PDL-1 expression, HER2 resistance, and tumor microenvironment (TME) (Table 1).